MYRIAD GENETICS INC (MYGN)

US62855J1043 - Common Stock

18.5  -0.01 (-0.05%)

After market: 18.5 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
690.6M
8.14%		678.4M
-1.77%		753.2M
11.03%		843.21M
11.95%
EBITDA
YoY % growth
-63.9M
-6.50%		-71M
-11.11%		-75M
-5.63%		31.912M
142.55%
EBIT
YoY % growth
-126.7M
4.02%		-123.7M
2.37%		-136.9M
-10.67%		3.066M
102.24%
Operating Margin
-18.35%-18.23%-18.18%0.36%
EPS
YoY % growth
0.02-0.30
-1,600.00%		-0.28
6.67%		0.02
108.21%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.10
50.66%
Revenue
Q2Q % growth		197.12M
8.79%
EBITDA
Q2Q % growth		-3.295MN/AN/AN/AN/A
EBIT
Q2Q % growth		-10.796M
79.32%		N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 0.04
133.33%		0.010.03208.06%
Q3 2023
Q2Q % growth		 -0.03
84.21%		-0.080.0563.74%
Q2 2023
Q2Q % growth		 -0.08
-300.00%		-0.090.017.73%
Q1 2023
Q2Q % growth		 -0.21
-600.00%		-0.20-0.01-6.49%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 196.6M
10.57%		198.68M-2.08M-1.05%
Q3 2023
Q2Q % growth		 191.9M
22.70%		182.82M9.08M4.97%
Q2 2023
Q2Q % growth		 183.5M
2.34%		190.87M-7.37M-3.86%
Q1 2023
Q2Q % growth		 181.2M
9.88%		174.98M6.22M3.55%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -238.6% -3.3% -58.64%
Revenue0% -1.13% 0.06% 1.08%